Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Children versus adults: pharmacokinetic and adverse-effect differences.

Anderson GD.

Epilepsia. 2002;43 Suppl 3:53-9. Review.

2.

Metabolism of antiepileptic medication: newborn to elderly.

Leppik IE.

Epilepsia. 1992;33 Suppl 4:S32-40. Review.

PMID:
1425492
3.

Lamotrigine-associated rash: risk/benefit considerations in adults and children.

Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, Richens A, Stern RS, Trevathan E.

Epilepsia. 1999 Jul;40(7):985-91. Review.

4.

Lamotrigine-induced severe cutaneous adverse reactions.

Schlienger RG, Shapiro LE, Shear NH.

Epilepsia. 1998;39 Suppl 7:S22-6. Review.

5.

Antiepileptic drugs in development: prospects for the near future.

Leppik IE.

Epilepsia. 1994;35 Suppl 4:S29-40. Review.

PMID:
8174517
6.

Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.

Biton V.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1009-18. Review.

PMID:
17125413
7.

Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.

Hirsch LJ, Weintraub D, Du Y, Buchsbaum R, Spencer HT, Hager M, Straka T, Bazil CW, Adams DJ, Resor SR Jr, Morrell MJ.

Neurology. 2004 Sep 28;63(6):1022-6. Review.

PMID:
15452293
8.

Idiosyncratic reactions: new methods of identifying high-risk patients.

Glauser TA.

Epilepsia. 2000;41 Suppl 8:S16-29. Review.

9.

Lamotrigine.

Matsuo F.

Epilepsia. 1999;40 Suppl 5:S30-6. Review.

10.

Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase.

Star K, Edwards IR, Choonara I.

PLoS One. 2014 Oct 10;9(10):e108970. doi: 10.1371/journal.pone.0108970. eCollection 2014. Review.

11.

Idiosyncratic adverse reactions to antiepileptic drugs.

Zaccara G, Franciotta D, Perucca E.

Epilepsia. 2007 Jul;48(7):1223-44. Epub 2007 Mar 26. Review.

12.

Adult experience with lamotrigine.

Willmore LJ, Messenheimer JA.

J Child Neurol. 1997 Nov;12 Suppl 1:S16-8. Review.

PMID:
9429125
13.

Lamotrigine: pharmacokinetics.

Garnett WR.

J Child Neurol. 1997 Nov;12 Suppl 1:S10-5. Review.

PMID:
9429124
14.

Carnitine in the treatment of valproic acid-induced toxicity.

Lheureux PE, Hantson P.

Clin Toxicol (Phila). 2009 Feb;47(2):101-11. doi: 10.1080/15563650902752376. Review.

PMID:
19280426
15.

Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.

Silva MF, Aires CC, Luis PB, Ruiter JP, IJlst L, Duran M, Wanders RJ, Tavares de Almeida I.

J Inherit Metab Dis. 2008 Apr;31(2):205-16. doi: 10.1007/s10545-008-0841-x. Epub 2008 Apr 4. Review.

PMID:
18392741
16.

The tolerability of lamotrigine in children.

Messenheimer JA, Giorgi L, Risner ME.

Drug Saf. 2000 Apr;22(4):303-12. Review.

PMID:
10789824
17.

Valproic Acid Metabolism and its Consequences on Sexual Functions.

Verrotti A, Mencaroni E, Cofini M, Castagnino M, Leo A, Russo E, Belcastro V.

Curr Drug Metab. 2016;17(6):573-81. Review.

PMID:
27000076
18.

Valproate: a simple chemical with so much to offer.

Peterson GM, Naunton M.

J Clin Pharm Ther. 2005 Oct;30(5):417-21. Review. No abstract available.

PMID:
16164485
19.

Liver.

Piñeiro-Carrero VM, Piñeiro EO.

Pediatrics. 2004 Apr;113(4 Suppl):1097-106. Review.

PMID:
15060205
20.

Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.

Felker D, Lynn A, Wang S, Johnson DE.

Expert Rev Clin Pharmacol. 2014 Mar;7(2):211-8. doi: 10.1586/17512433.2014.871202. Epub 2014 Jan 22. Review.

PMID:
24450420

Supplemental Content

Support Center